Literature DB >> 30069605

Diabetic Foot Infections: Update on Management.

Maria Nikoloudi1, Ioanna Eleftheriadou1, Anastasios Tentolouris1, Ourania A Kosta1, Nikolaos Tentolouris2.   

Abstract

PURPOSE OF REVIEW: Diabetic foot infections (DFIs) are common in patients with diabetes mellitus complicated by foot ulcers and can be classified in different categories based on their severity. In this report, we present the diagnosis and management of DFIs according to their classification. RECENT
FINDINGS: While appropriate antibiotic regiments and surgical techniques for the treatment of DFIs are well established, new technologies and techniques for example in medical imaging, wound care modalities, and supplementary therapy approaches show potentially promising results in preventing DFIs. As with every complex disease, fine tuning DFI management can be challenging as it requires careful evaluation of different parameters. It demands timely action, close collaboration of different specialties, and patient cooperation.

Entities:  

Keywords:  Diabetic foot; Infection; Multidrug resistance organisms; Osteomyelitis; Treatment

Year:  2018        PMID: 30069605     DOI: 10.1007/s11908-018-0645-6

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  77 in total

Review 1.  Topical antimicrobial therapy for treating chronic wounds.

Authors:  Benjamin A Lipsky; Christopher Hoey
Journal:  Clin Infect Dis       Date:  2009-11-15       Impact factor: 9.079

Review 2.  A systematic review of maggot debridement therapy for chronically infected wounds and ulcers.

Authors:  Xinjuan Sun; Kechun Jiang; Jingan Chen; Liang Wu; Hui Lu; Aiping Wang; Jianming Wang
Journal:  Int J Infect Dis       Date:  2014-05-16       Impact factor: 3.623

Review 3.  Diabetic foot infections: what have we learned in the last 30 years?

Authors:  Ilker Uçkay; Javier Aragón-Sánchez; Daniel Lew; Benjamin A Lipsky
Journal:  Int J Infect Dis       Date:  2015-10-13       Impact factor: 3.623

Review 4.  The Role of Biomarkers to Diagnose Diabetic Foot Osteomyelitis. A Meta-analysis.

Authors:  Suzanne Aura Victoria van Asten; Edgar Joseph Geradus Peters; Yin Xi; Lawrence Alfred Lavery
Journal:  Curr Diabetes Rev       Date:  2016

Review 5.  Pressure-relieving interventions for treating diabetic foot ulcers.

Authors:  Jane Lewis; Allyson Lipp
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

6.  Procalcitonin as a diagnostic aid in diabetic foot infections.

Authors:  Gunalp Uzun; Emrullah Solmazgul; Hayrettin Curuksulu; Vedat Turhan; Nurittin Ardic; Cihan Top; Senol Yildiz; Maide Cimsit
Journal:  Tohoku J Exp Med       Date:  2007-12       Impact factor: 1.848

7.  Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact.

Authors:  A Hartemann-Heurtier; J Robert; S Jacqueminet; G Ha Van; J L Golmard; V Jarlier; A Grimaldi
Journal:  Diabet Med       Date:  2004-07       Impact factor: 4.359

8.  Quantitative aerobic and anaerobic bacteriology of infected diabetic feet.

Authors:  F L Sapico; H N Canawati; J L Witte; J Z Montgomerie; F W Wagner; A N Bessman
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

Review 9.  Diabetic foot osteomyelitis.

Authors:  A Hartemann-Heurtier; E Senneville
Journal:  Diabetes Metab       Date:  2008-01-31       Impact factor: 6.041

10.  Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study.

Authors:  A Jeandrot; J-L Richard; C Combescure; N Jourdan; S Finge; M Rodier; P Corbeau; A Sotto; J-P Lavigne
Journal:  Diabetologia       Date:  2007-10-13       Impact factor: 10.122

View more
  2 in total

Review 1.  Immune aging in diabetes and its implications in wound healing.

Authors:  J Moura; P Madureira; E C Leal; A C Fonseca; E Carvalho
Journal:  Clin Immunol       Date:  2019-02-05       Impact factor: 3.969

2.  Effects of adding adjunctive hyperbaric oxygen therapy to standard wound care for diabetic foot ulcers: a protocol for a systematic review with meta-analysis and trial sequential analysis.

Authors:  Julie Vinkel; Niels Frederich Rose Holm; Janus C Jakobsen; Ole Hyldegaard
Journal:  BMJ Open       Date:  2020-06-29       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.